We are live on
!
Find out more
BMO
Beck Mack & Oliver Portfolio holdings
AUM
$5.13B
1-Year Est. Return
11.51%
This Fund
S&P 500
This Quarter
Est. Return
+13.57%
1 Year Est. Return
+11.51%
3 Year Est. Return
+68.19%
5 Year Est. Return
+90.4%
10 Year Est. Return
+384.43%
AUM
$2.8B
AUM Growth
+$303M
(+12%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
39.02%
Holding
238
New
13
Increased
24
Reduced
115
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Drainage Systems
WMS
|
+$18.5M |
| 2 |
Sherwin-Williams
SHW
|
+$16.1M |
| 3 |
Wabtec
WAB
|
+$12.8M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$12M |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$10.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Markel Group
MKL
|
+$12.7M |
| 2 |
Dover
DOV
|
+$7.69M |
| 3 |
OAK
OAKTREE CAPITAL GROUP, LLC
OAK
|
+$7.17M |
| 4 |
Liberty Global Class A
LBTYA
|
+$5.59M |
| 5 |
Abbott
ABT
|
+$4.78M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.52% |
| 2 | Healthcare | 18.76% |
| 3 | Technology | 12.79% |
| 4 | Communication Services | 10.56% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Verrica Pharmaceuticals
VRCA
$97.7M
| $108K | ﹤0.01% |
1,000
| – | – |
|
|
PBT
202
Permian Basin Royalty Trust
PBT
$1.58B
| $82K | ﹤0.01% |
10,900
| – | – |
|
|
ESTR
203
DELISTED
Estre Ambiental, Inc.
ESTR
| $81K | ﹤0.01% |
50,050
-15,150
| -23% | -$28.1K |
|
|
AGFSW
204
DELISTED
AgroFresh Solutions Inc Warrants
AGFSW
| $79K | ﹤0.01% |
+881,003
| New | +$97.8K |
|
|
AVB
205
DELISTED
AvalonBay Communities
AVB
| – | – |
-1,237
| Closed | -$215K |
|
206
Chubb
CB
$131B
| – | – |
-1,639
| Closed | -$212K |
|
|
FITB
207
Fifth Third Bancorp
FITB
$49.5B
| – | – |
-13,500
| Closed | -$318K |
|
208
iShares Russell 1000 ETF
IWB
$49.1B
| – | – |
-2,525
| Closed | -$350K |
|
|
K
209
DELISTED
Kellanova
K
| – | – |
-5,964
| Closed | -$319K |
|
210
KeyCorp
KEY
$23.4B
| – | – |
-10,000
| Closed | -$148K |
|
|
AMPE
211
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| – | – |
-42
| Closed | -$5K |
|
|
PCMI
212
DELISTED
PCM, Inc
PCMI
| – | – |
-20,950
| Closed | -$369K |
|
|
CYTR
213
DELISTED
CytRx Corp
CYTR
| – | – |
-25,000
| Closed | -$11K |
|
|
VCMP
214
DELISTED
VCAMPUS CORP
VCMP
| $0 | ﹤0.01% |
59,956
| – | – |
|
Similar funds
ACM
BPCE
SGM
CFO
SB
CCM
MRCP
KACA
Beck Mack & Oliver's Q1 2019 Portfolio in Review
As of Q1 2019, Beck Mack & Oliver held 238 positions worth $2.8B, up 12% from $2.49B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Beck Mack & Oliver's Q1 2019 filing shows 13 new, 24 increased, 115 reduced and 13 closed positions. Its largest new stake was Advanced Drainage Systems: 730,425 shares worth $18.8M. The largest sale was Markel Group, an estimated $12.7M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Healthcare and Technology.
- Beck Mack & Oliver's largest Q1 2019 buy was Advanced Drainage Systems: 730,425 shares worth $18.8M.
- Beck Mack & Oliver added most to Sherwin-Williams in Q1 2019, an estimated $16.1M increase.
- Beck Mack & Oliver's biggest Q1 2019 reduction was Markel Group, cutting an estimated $12.7M.
- Beck Mack & Oliver fully exited PCM, Inc in Q1 2019, selling an estimated $369K.
- Beck Mack & Oliver's ten largest holdings make up 39% of its $2.8B portfolio in Q1 2019.
- Beck Mack & Oliver opened 13 new positions and closed 13 in Q1 2019.
- Beck Mack & Oliver's portfolio value rose 12% quarter-over-quarter to $2.8B.
Based on Beck Mack & Oliver's 13F filing for Q1 2019, filed 2 May 2019.